DCTH MEXC RealStocks
Own real DCTH shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-13 09:36:00. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Delcath Systems Inc. (DCTH) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $21.31, with a market capitalization of $757.34M and a P/E ratio of 113.82. Over the past 52 weeks, its price has ranged from $8.12 to $22.51. This page covers its latest market performance, valuation, price trends and company information.
$757.34M | |
$21.60 | |
$21.60 | |
$20.25 | |
$21.38 | |
-- | |
483.62K | |
113.82 | |
$22.51 | |
$8.12 | |
-- | |
-- |
Delcath Systems Inc. (DCTH) is trading at $21.31 in pre-market trading as of 2026-11-13 09:10:00, down 0.33% ($0.07) from the previous close of $21.38
Pre-market trading shows how investors are pricing DCTH before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.
Over the past seven days, Delcath Systems Inc. (DCTH) moved from $14.82 to $21.31, representing a gain of 43.79% ($6.49).
The stock traded between $14.24 and $22.51 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1.50 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 91.7%
DCTH is currently trading at $21.31, placing it 91.7% of the way from its 52-week low of $8.12 to its 52-week high of $22.51. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 156 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Delcath Systems Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Delcath Systems Inc. (DCTH) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to DCTH, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between DCTH shares and USD.
DCTH Shares to USD
1.00 DCTH shares = 21.31 USD
Calculations are estimates based on the latest available price and are for reference only.